Cell Therapy Market: Global Industry Analysis and Forecast (2022-2029)

Cell Therapy Market size was valued at US$ 8.92 Bn. in 2021 and is expected to reach US$ 25.47 Bn. by 2029, at CAGR of 14.00% during forecast period 2022-2029. Stem Cell is one of the dominating segments reviewed in our report is dominating the Global Cell Therapy Market.
Cell Therapy Market Overview:
Cellular Therapy is the insertion of a human cell to replace or repair the damaged tissue or cell. Therapy generally include viable cells which are compatibly injected, implanted, or grafted into the patient's body which can create a medicinal effect T- cell and Stem Cell are the type of cell therapy that is used in the fight against cancer with cell mediated immunity or to regenerate damaged tissues. Cell Therapy has become a widely used treatment for patients with long-term illnesses.



To know about the Research Methodology :- Request Free Sample Report
Cell Therapy Market Dynamics:
The increasing number of chronic diseases is the vital factor accelerating market growth as new regenerative technologies are emerging at a fast pace and are widely accepted by a large population due to the high success rate of the therapy. There are several guidelines towards the benefits of cell therapy and allocating the funds for research to further push the technology and make it more affordable and easily accessible to developing countries. The growth in the demand for precision medicinal treatments in oncology in which patients receive personalized treatments makes it a lucrative opportunity for the cell therapy market to expand.

The field of regenerative medicine is undergoing many advances that are still expected to provide effective therapeutic solutions for chronic diseases. Some companies in emerging markets, such as Canada, are at the forefront of taking advantage of the untapped potential of the cell therapy market. For example, RepliCel is investing in several regenerative medicine projects. For example, in February 2021, the company announced plans to commercialize and clinically test three additional technologies in Japan. This includes two cell-based therapies. One is for skin rejuvenation and the other is for tendon regeneration.

The gradual emergence of new technologies that support the development of advanced therapies is contributing to the growth of the market. Introducing your cell line is considered the primary tool for creating a strong portfolio of candidates using a single product. For example, Immunicum is advancing its immuno-oncology product line with the proliferation of chimeric antigen receptor T cells (CART), new antigen presentation technology for dendritic cells, and T cell primers.

Direct Cell Reprogramming has received noteworthy consideration as a novel therapeutic strategy. This treatment has the highest rate of efficacy and safety. Currently, Fortuna Company considering commencing clinical use of neural stem cells of patients which will be generated by straight reprogramming for replacement of lost neuronal tissue which is the future of the cell therapy market.
Cell Therapy Market Segment Analysis:
By Therapy Type, The autologous treatment segment dominated the cell therapy market, with the largest share in 2021 at 53.2%. The segment is expected to maintain its dominance over the forecast period. This can be due to several benefits associated with autologous transplantation, such as B. Easy to obtain, no need to identify HLA-matched donors, low risk of life-threatening complications, no risk of GvHD, no need for immunosuppressive therapy. In addition, autologous therapies are more affordable compared to allogeneic therapies, which is further due to segment growth. Due to the high cost and relatively low recurrence rate associated with allogeneic transplantation, the halotherapy segment is expected to experience relatively slow growth from 2021 to 2029. However, the growth of cell banking and the relocation of companies to the development of allogeneic therapeutic products are driving the cell therapy market.

By  Cell Type, Stem Cell is dominating the global cell therapy market. The stem cell segment is expected to continue throughout the forecast period as the stem cell segment will dominate the global cell therapy market in 2021 and become more popular with various government initiatives. The number of stem cell banks in developing countries is increasing, which is driving the growth of the cell therapy market. In addition, raising awareness of stem cell storage has a positive impact on the cell therapy market.



By Application, Autoimmune Disorder is dominating the Global Cell Therapy Market. Currently, cell therapy is a potential treatment for cancer, autoimmune disorder disease, and other infectious diseases with more than 40% of the application in given treatments. Hematopoietic stem cell transplant is the most frequent cell therapy opted in many Asian as well as in North America. Potential applications of cell therapies include treating cancers, autoimmune disease, urinary problems, and infectious disease, rebuilding damaged cartilage in joints, repairing spinal cord injuries, improving a weakened immune system, and helping patients with neurological disorders. This application in such treatment boosted the growth in Global Cell Therapy Market.

By End User, The Academics and Research Institute segment dominated the cell therapy market, with the largest share in 2021 at 60.9% globally. Stem cells are primarily used in research projects and have a high market share in the research segment. The region is expected to continue its dominance from 2022 to 2029. Cell-based therapies have great potential to replace, repair, repair, or regenerate damaged tissues, cells, and organs. Researchers are investing heavily in developing such effective and safe treatments as an alternative to traditional treatment strategies.
Cell Therapy Market Regional Insights:
North America is dominating the global cell therapy market. North America held a total market share of 52.7% in 2021 as the new institutions and centers are expanding in R&D to push the growth in cell therapy. From the leading universities in the US which are involving new research in cell regenerative technology including Institute for Stem Cell Biology and regenerative medicine, Stanford University, Harvard Stem Cell Institute, and Yale Steam Cell Center.

The Asia Pacific is expected to project substantial growth of 15.52% during the forecasted period. Countries like China, South Korea, and Japan are heavily investing in regenerative treatments and stem cell therapy. Certain government-funded institutes are focused on the Research and Development aiming to push the market.

FDA approved an investigational new drug to Stemedica Cell Technologies which is likely to boost the market.The objective of the report is to present a comprehensive analysis of the Global Cell Therapy market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding the Global Cell Therapy market dynamics, structure by analyzing the market segments and projecting the Global Cell Therapy market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Cell Therapy market make the report investor’s guide.
Cell Therapy Market Scope: Inquire before buying



Global Cell Therapy Market


Report Coverage
Details


Base Year:
2021
Forecast Period:
2022-2029


Historical Data:
2017 to 2021
Market Size in 2021:
US $ 8.92 Bn.


Forecast Period 2022 to 2029 CAGR:
14.00%
Market Size in 2029:
US $ 25.47 Bn.


 Segments Covered:
by Therapy Type
• Autologous
• Allogeneic


by Cell Type
• T-Cell
• Stem Cell


by Application
• Malignancies
• Musculoskeletal Disorder
• Autoimmune Disorder
• Dermatology
• Others


by End-User
• Hospitals and clinics
• Academics and Research Institutes



Cell Therapy Market, by Region
• North America
• Europe
• Asia Pacific
• The Middle East and Africa
• South America
Cell Therapy Market Key Players
• Kolon Tissue Gene Inc.
• Anterogen Co. Ltd.
• JCR Pharmaceuticals Co., Ltd.
• Castle Creek Biosciences, Inc.
• The Future of Biotechnology, MEDIPOST
• Osiris Therapeutics, Inc.
• PHARMICELL Co., Ltd
• Tameika Cell Technologies, Inc.
• Cells for Cells
• NuVasive, Inc.
• Vericel Corporation
• Celgene Corporation
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Danaher Corporation
• Becton, Dickinson, and Company
• Lonza Group
• Sartorius AG
• Terumo BCT
• Fresenius Medical Care AG & Co. KGaA

Frequently Asked Questions:

1. Which region has the largest share in Global Cell Therapy Market Market?
Ans: North America region holds the highest share in 2021.

2. What is the growth rate of Global Cell Therapy Market Market?
Ans: The Global Cell Therapy Market Market is growing at a CAGR of 14.00% during forecasting period 2022-2029.

3. What is scope of the Global Cell Therapy Market market report?
Ans: Global Cell Therapy Market Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Cell Therapy Market market?
Ans: The important key players in the Global Cell Therapy Market Market are –
Kolon TissueGene Inc., Anterogen Co. Ltd., JCR Pharmaceuticals Co., Ltd., Castle Creek Biosciences, Inc., The Future of Biotechnology, MEDIPOST, Osiris Therapeutics, Inc., PHARMICELL Co., Ltd, Tameika Cell Technologies, Inc., Cells for Cells, NuVasive, Inc., Vericel Corporation, Celgene Corporation, Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Becton, Dickinson, and Company, Lonza Group, Sartorius AG, Terumo BCT, and Fresenius Medical Care AG & Co. KGaA

5. What is the study period of this market?
Ans: The Global Cell Therapy Market Market is studied from 2021 to 2029.